1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type ; Drug Type ; Therapeutic Indication ; Dosage form, and Geography

Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type ; Drug Type ; Therapeutic Indication ; Dosage form, and Geography

  • July 2019
  • 169 pages
  • ID: 5806289
  • Format: PDF
  • By The Insight Partners

Summary

Table of Contents

Search Inside

The global Antifungal Drugs market is expected to reach US$ 13,524.2 Mn in 2027 from US$ 10,182.3 Mn in 2018. The market is estimated to grow with a CAGR of 3.2% from 2019-2027.
The market is driven by the factors such as, rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market.
The significantly rising incidences of the fungal infections among others are the leading factors for the market growth.
There are millions of various types of fungi on Earth, but only around 300 are identified as the one who makes people sick.Fungal infections are mainly caused due to microscopic fungi, which is common in the atmosphere.

Fungi live outside in soil and on plants and various indoor surfaces and human skin.
The rising number of fungal infections are causing harm to patients.Candidemia is among the most common bloodstream infections in the United States.

For instance, according to the Centers for Disease Control and Prevention (CDC), from 2013 to 2017, the average incidence of fungal infection was around 9 per 100,000 people.Though, this number changes as per the geographic location and patient population.

CDC predicts that approximately 25,000 cases of candidemia occur across the country per year.
There has been significant variation in the rates of candidemia by age group.The rates have reduced considerably in infants, but it remains higher as compared to other groups.

Candidemia rates are majorly high in people aged above 65 and older.The reasons for the difference in incidence by age, race may be due to the alteration in underlying circumstances, socioeconomic status, and other factors.

The prevalence of Candidaemia in established countries has been related to the age of patients. The below is the country estimated burden of Candidaemia.
Moreover, due to the tropical climate, South Asia has a high frequency of fungal infections. For instance, according to a report published by Down To Earth organization in 2015, infection from yeast, which is a type of fungus, is 0.8 among 1,000 patients in the US. Moreover, the incidence is found to be 0.2 and 0.9 per 1,000 patients in Europe and Australia, respectively. However, in India, approximately, 1-12 cases occur in every 1,000 patients that are affected by the fungal infection. Therefore, demand for the anti-fungal drugs is increasing owing to providing treatment and helps in maintaining the proper immunity to the patients. Thus, the rising rate of fungal infections are likely to drive the market for anti-fungal drugs in the coming years
Some of the major primary and secondary sources included in the report for the Antifungal Drugs market are World Health Organization, National Institute of Health and Medical Research, Centers for Disease Control and Prevention, The New England Journal of Medicine, Journal of Fungi among the others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($4550)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2019

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2019

  • $ 2000
  • August 2019

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis (Tinea Unguium) - Pipeline Review, H2 ...

Global Tinea Pedis (Athlete’s Foot) Treatment Industry

Global Tinea Pedis (Athlete’s Foot) Treatment Industry

  • $ 5450
  • October 2019

Tinea Pedis (Athlete’s Foot) Treatment market worldwide is projected to grow by US$215.3 Million, driven by a compounded growth of 3.1%. Oral, one of the segments analyzed and sized in this study, displays ...

Digestive Remedies Markets in China

Digestive Remedies Markets in China

  • $ 4000
  • August 2019

China’s demand for Digestive Remedies has grown at a fast pace in the past decade.In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...


Download Unlimited Documents from Trusted Public Sources

OTC Industry Analysis - Forecast

  • October 2019
    13 pages
  • OTC  

    Antifungal  

  • United States  

    North America  

    Europe  

View report >

OTC Markets

  • October 2019
    8 pages
  • OTC  

View report >

Antifungal Demographic Impact in India

  • September 2019
    8 pages
  • Hospital  

    Antifungal  

  • India  

View report >

OTC Industry in Brazil 4 months ago

OTC Markets in the US 9 months ago

OTC Markets in Poland 11 months ago


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on